Myasthenia Gravis Rare Disease Network | Rare Diseases Clinical Research Network

Rare Disease Research Challenges, Opportunities Due to COVID-19 Featured in New Article sheila.wolfer@… Tue, 05/04/2021 - 12:40

Challenges in conducting clinical research in the midst of the COVID-19 pandemic are spotlighted in an article from three consortia of the Rare Diseases Clinical Research Network (RDCRN). Their contribution was featured in the latest issue of Rare Neurological Diseases Special Report.

Frontiers in Congenital Disorders of Glycosylation Consortium

FCDGC

Myasthenia Gravis Rare Disease Network

MGNet

Global Leukodystrophy Initiative Clinical Trials Network

GLIA-CTN

Subscribe to Myasthenia Gravis Rare Disease Network

The Rare Diseases Clinical Research Network (RDCRN) is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Office of Rare Diseases Research (ORDR). The RDCRN websites are hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818.